Narcotics research, rehabilitation, and treatment. Hearings, Ninety ...
Narcotics research, rehabilitation, and treatment. Hearings, Ninety ... Narcotics research, rehabilitation, and treatment. Hearings, Ninety ...
470Studies on the waj^s in which tolerance or physical dependence develops focuson biochemical, pharmacological, and behavioral measures associated with toleranceto narcotic analgesics such as morphine. In an eflfort to understand how addictionoccurs, these studies are exploring the effects of narcotic analgesics onbrain proteins, R,NA, and brain transmitters.In studjang the effects of drugs of abuse in animals and humans, researchersare exploring both long- and short-term effects and effects of both small andlarge doses. Studies are concentrating on the effects of drugs on coordination,thinking, perception, memory, and complex acts such as driving. Research is alsobeing carried out on the potential genetic and carcinogenic effects of these drugs,as well as on their effects on developing fetuses.Research into detecting abused drugs in body tissues and fluids includes researchon opiates, barbiturates, marihuana, amphetamines, and hallucinogens.Better methods of detection will help those who are treating drug abusers andshould reduce the expense, complexitj', and error involved in screening andmonitoring both i^atients and prisoner suspected of drug use. More sophisticatedmethods for quantifying and differentiating various types of drugs will also beuseful to forensic pathologists and medical examiners.Much research is now underway to evaluate the effectiveness of treatmentand rehabilitation methods in the field of narcotic addiction. We are evaluatingboth pharmacological approaches, such as the narcotic antagonists and methadone,and nonpharmacoiogical methods such as therapeutic communities, comprehensivecenters, and desensitization techniques. As members of the conmiitteelasiy know, the Institute supports the treatment of addicts both under the civilcommitment program of the Narcotic Addict Rehabilitation Act and under a grantprogram to establish community-based treatment centers, of which approximateh-16 are now operating and another seven have been funded and are getting underway.In addition, under Public Law 91-513, the Institute is now authorized tofund individual treatment services such as detoxification centers, partial hospitalization,or emergency care.Both the civil commitment program and the community-based comprehensivetreatment centers empio.y pharmacological and nonpharmacoiogical methodsof treatment, and data is being gathered to evaluate the relative efficacy ofthese methods.I should stress that we believe that no one method of treating narcotic addictsis "the answer." Addicts differ in their needs and in the kinds of therapy whichare most helpful to them. As a result, it is necessary to evaluate a variety oftreatment modalities.As of March 1971, the narcotic treatment and rehabilitation programs supportedby the Institute were assisting approximately 2,000 patients under thecivil commitment program, of whom 1,300 were in the aftercare phase of treatment,and approximately 7,000 patients in the community-based treatmentprograms supported by Institute grants. Unfortunately, we cannot at presentcompare the results of the civil commitment treatment program and the communitytreatment programs because the}^ are treating different groups of addicts.However, at a later date it should be possible to extract matched pairs of patientsfrom the two groups and compare their degree of benefit. To illustrate the differencesin the two groups, addicts being treated under the civil commitment programare 60 percent white and have an average age in the late twenties; whereas,the patients being treated in the community centers are over two-thirds blackor Chicano and have an average age in the early to midtwenties. Moreover,the two groups are not equivalent in terms of employment histories, arrest histories,or education. What we can say now, however, is that both programs seemto be helping a large percentage of the patient populations whom they are trenting.The exact percentage of patients who are being helped depends on what measure3^ou use to evaluate the patients' improvement. For example, you can look atthe percent of patients who are working, or the percent who are staying out ofjail, the percent who do not become readdictcd, the percent who have returned toschool, and so on. In the civil commitment program, a study of 1,200 patients whowere in aftercare in 1970 showed that approximately So percent wei-e enii)loy('ti,70 percent wore not nrrestod and spent no time in jail during that jxn-iod, 3.")percent wore in self-help therapy, and 33 percent were pursuing their education.In addition, SO percent of the patients who had been in aftercare for 3 monthsor more were completely free of heroin use. A similar statement can be maderegarding the heroin use of patients who were in the community tr(^atnientprograms. As you know, many patients during the treatment of their addictionmay abuse drugs other than heroin occasionally, such as cocaine, marihuana,
471ainpheta.mines, or barbiturates. Of the patients in the civil commitment programwho had been in aftercare for 3 months or more, 60 percent were not abusing anydrugs. The same is true of patients who had been in the community treatmentprogram for 3 months or more. Of the patients who are in the civil comtmitmentaftercare phase, we know that 60 percent do not become readdicted during theirfirst year in aftercare. Of the remaining, 25 percent do abuse some drugs or becomereaddicted and require further hospital treatment. The remaining 15 percentdrop out of the program.There is a great deal of public interest currently in methadone maintenancetreatment for narcotic addiction. Many claims and counterclaims are beingmade regarding its effectiveness. How effective is methadone maintenancetreatment? The answer I am about to give you is a cautious one, but I believerepresents the state of our knowledge at this time. The Food and Drug Administration,which has responsibility for determining the degi-ee of safety and efficacyof drugs, has determined that the exact degree of safety and efficacy of methadonemaintenance treatment in unknown at this time. Many groups, including groupsin New York City, Illinois, and here in Washington, D.C., are evaluating methadonemaintenance. The National Institute of Mental Health is currentlj' sponsoringthe use of methadone in both its civil commitment treatment program andits community-based treatment in-ograms under carefully controlled conditionsso that we can generate data to help determine methadone's safety and efficacy.With regard to comparing methadone and other treatment modalities, I mustagain point out that the patients who are being treated with methadone differin many characteristics from the patients who are being treated with othermodalities. For example, they differ in age, sex, race, length of addiction, historyof criminal behavior, and so on. Lastly, I might again say that comparisons ofefficacy depend on which measures or benefits one looks at—employment,arrest records, drug abuse, or pursuit of education. At the present time I do notknow of any conclusive studies which demonstrate significant differences betweenthe benefits achieved by methadone patients compared with the benefits achievedby patients treated in other waj's.It might be good to mention here that we are studying other narcotic substituteswhich ma}^ be longer acting than methadone. One drug we are testing isL-alpha-acetyl-methadol, whose effects last for 48 to 72 hours, and if successful,wall mean that patients could come in from treatment only two to three timesa week rather than every day. This would greatly decrease the cost of a maintenanceprogram and allow the patient to live a more normal life. We are also supportingresearch into tiie development of a nontoxic removable implant which candeliver an antagonist drug slowly into the patient's system over a period of timeso that the need for repeated medication would be markedly reduced. A fullysafe and effective antagonist, however, has not yet been developed.Mr. Chairman, my overview of the Intsitute's research program would not becomplete unless I mentioned three additional activities. First, the Institute'sprogram of supplying standardized pure preparations of drugs of abuse to qualifiedresearchers. Originally this program focused on distributing LSD to researchersthrough the joint FDA-NIMH Psychotomimetric Agents Advisory Committee.With the increased use of marihuana and related drugs, the program has expandedto include a wider spectrum of drugs, including psilocybin, radioactively taggedand untagged tetrahydrocannabinol (Delta-8 and Delta-9 THC), a uniformstandard grade of marihuana leaf, and most recentlj- heroin for research purposes.At present the Institute is not only supplying requests from the U.S. investigatorsbut has estabhshed procedures with the Canadian Food and DrugDirectorate and the United Nations Narcotics Laboratory for supplying anddistributing these drugs for research in Canada and Western Europe. Informationgenerated by research performed in foreign countries should help the U.S. researchprogram. The number of requests for research drugs has doubled in the past year.Since this program's inception, 650 requests for research drugs have been filled,250 of them for marihuana or its derivatives.Second, the Institute is currently pretesting a number of educational materialsincluding pamphlets, posters, workbooks, and films to determine their usefulnessin reaching different groups within the population. Materials which pass thispretesting phase will be ready for release in the fall of this year. Some of thematerials and educational materials which have previously been developed throughthe National Clearinghouse for Drug Abuse Information have been used in theInstitute's training program, which in fiscal j^ear 1970 provided 1- and 2-weekcourses on drug abuse for over 1,500 professionals, allied health workers, Governmentofficials, and members of the public.
- Page 439 and 440: 419On the other hand, if serious si
- Page 441 and 442: 421of the best known programs. Alth
- Page 443 and 444: 423Medical Association, American Ps
- Page 445 and 446: 425of the United States Pharmacopei
- Page 447 and 448: 4275. Repeated examinations. Physic
- Page 449 and 450: 429agement and rehabilitation of se
- Page 451 and 452: —431As the agenc.v within HEW whi
- Page 453 and 454: 433and complex acts such as driving
- Page 455 and 456: 435(Inig induces physical and psych
- Page 457 and 458: 437Chiiirmtin Pepper. Doctor, I thi
- Page 459 and 460: 439A large proportion of youngsters
- Page 461 and 462: 441Dr. Brown, what would you say is
- Page 463 and 464: 443Chairmiui Pepper. Wliat is tlie
- Page 465 and 466: 446The state of the art is promisin
- Page 467 and 468: 447Lot nie ask you first, is tlic d
- Page 469 and 470: 449Chairman Pepper. Do you happen t
- Page 471 and 472: 451want you to take a look at. We w
- Page 473 and 474: 453In addition to that, there seems
- Page 475 and 476: 455the Mfldict is having a program
- Page 477 and 478: 457—on drugs? By that I mean, vei
- Page 479 and 480: 459\\ e are basically saying, in or
- Page 481 and 482: —;461that this is the extent to w
- Page 483 and 484: 463We could go into the drug area a
- Page 485 and 486: .465program that was i)ut into Jack
- Page 487 and 488: 467Mr. Brasco. Possibly. However, w
- Page 489: 469him, arrange to get somebody els
- Page 493 and 494: 473In the meantime, the Institute d
- Page 495 and 496: 475treated in the community centers
- Page 497 and 498: 477research on narcotics in the sam
- Page 499 and 500: 479c 53 03E
- Page 501 and 502: NARCOTICS RESEARCH, REHABILITATION,
- Page 503 and 504: 483spending for research through NI
- Page 505 and 506: 485There has been no concerted seri
- Page 507 and 508: 487it is left in one of their veins
- Page 509 and 510: 489I do not think I should explain
- Page 511 and 512: 491Dr. ViLLARREAL. Until the reflex
- Page 513 and 514: 493evidence strongly shows is that
- Page 515 and 516: 495Chairman Pepper. One other quest
- Page 517 and 518: 497Dr. ViLLARREAL. So, it is a biol
- Page 519 and 520: '.499could result in a laboratory s
- Page 521 and 522: 5qifinds it in normal exploration.
- Page 523 and 524: 503synthesized a large number of na
- Page 525 and 526: 505STATEMENT OE DR. ALBERT KURLAND,
- Page 527 and 528: 507discovered if we iiad taken the
- Page 529 and 530: 509Mr. Perito. Dr. Kurland, do you
- Page 531 and 532: 511Chairman Pepper. Has the Food an
- Page 533 and 534: 513]Mr. Steiger. Do you feel from y
- Page 535 and 536: 515In this second study there was a
- Page 537 and 538: 517were any significant differences
- Page 539: 519The Deceptive Communication and
470Studies on the waj^s in which tolerance or physical dependence develops focuson biochemical, pharmacological, <strong>and</strong> behavioral measures associated with toleranceto narcotic analgesics such as morphine. In an eflfort to underst<strong>and</strong> how addictionoccurs, these studies are exploring the effects of narcotic analgesics onbrain proteins, R,NA, <strong>and</strong> brain transmitters.In studjang the effects of drugs of abuse in animals <strong>and</strong> humans, <strong>research</strong>ersare exploring both long- <strong>and</strong> short-term effects <strong>and</strong> effects of both small <strong>and</strong>large doses. Studies are concentrating on the effects of drugs on coordination,thinking, perception, memory, <strong>and</strong> complex acts such as driving. Research is alsobeing carried out on the potential genetic <strong>and</strong> carcinogenic effects of these drugs,as well as on their effects on developing fetuses.Research into detecting abused drugs in body tissues <strong>and</strong> fluids includes <strong>research</strong>on opiates, barbiturates, marihuana, amphetamines, <strong>and</strong> hallucinogens.Better methods of detection will help those who are treating drug abusers <strong>and</strong>should reduce the expense, complexitj', <strong>and</strong> error involved in screening <strong>and</strong>monitoring both i^atients <strong>and</strong> prisoner suspected of drug use. More sophisticatedmethods for quantifying <strong>and</strong> differentiating various types of drugs will also beuseful to forensic pathologists <strong>and</strong> medical examiners.Much <strong>research</strong> is now underway to evaluate the effectiveness of <strong>treatment</strong><strong>and</strong> <strong>rehabilitation</strong> methods in the field of narcotic addiction. We are evaluatingboth pharmacological approaches, such as the narcotic antagonists <strong>and</strong> methadone,<strong>and</strong> nonpharmacoiogical methods such as therapeutic communities, comprehensivecenters, <strong>and</strong> desensitization techniques. As members of the conmiitteelasiy know, the Institute supports the <strong>treatment</strong> of addicts both under the civilcommitment program of the Narcotic Addict Rehabilitation Act <strong>and</strong> under a grantprogram to establish community-based <strong>treatment</strong> centers, of which approximateh-16 are now operating <strong>and</strong> another seven have been funded <strong>and</strong> are getting underway.In addition, under Public Law 91-513, the Institute is now authorized tofund individual <strong>treatment</strong> services such as detoxification centers, partial hospitalization,or emergency care.Both the civil commitment program <strong>and</strong> the community-based comprehensive<strong>treatment</strong> centers empio.y pharmacological <strong>and</strong> nonpharmacoiogical methodsof <strong>treatment</strong>, <strong>and</strong> data is being gathered to evaluate the relative efficacy ofthese methods.I should stress that we believe that no one method of treating narcotic addictsis "the answer." Addicts differ in their needs <strong>and</strong> in the kinds of therapy whichare most helpful to them. As a result, it is necessary to evaluate a variety of<strong>treatment</strong> modalities.As of March 1971, the narcotic <strong>treatment</strong> <strong>and</strong> <strong>rehabilitation</strong> programs supportedby the Institute were assisting approximately 2,000 patients under thecivil commitment program, of whom 1,300 were in the aftercare phase of <strong>treatment</strong>,<strong>and</strong> approximately 7,000 patients in the community-based <strong>treatment</strong>programs supported by Institute grants. Unfortunately, we cannot at presentcompare the results of the civil commitment <strong>treatment</strong> program <strong>and</strong> the community<strong>treatment</strong> programs because the}^ are treating different groups of addicts.However, at a later date it should be possible to extract matched pairs of patientsfrom the two groups <strong>and</strong> compare their degree of benefit. To illustrate the differencesin the two groups, addicts being treated under the civil commitment programare 60 percent white <strong>and</strong> have an average age in the late twenties; whereas,the patients being treated in the community centers are over two-thirds blackor Chicano <strong>and</strong> have an average age in the early to midtwenties. Moreover,the two groups are not equivalent in terms of employment histories, arrest histories,or education. What we can say now, however, is that both programs seemto be helping a large percentage of the patient populations whom they are trenting.The exact percentage of patients who are being helped depends on what measure3^ou use to evaluate the patients' improvement. For example, you can look atthe percent of patients who are working, or the percent who are staying out ofjail, the percent who do not become readdictcd, the percent who have returned toschool, <strong>and</strong> so on. In the civil commitment program, a study of 1,200 patients whowere in aftercare in 1970 showed that approximately So percent wei-e enii)loy('ti,70 percent wore not nrrestod <strong>and</strong> spent no time in jail during that jxn-iod, 3.")percent wore in self-help therapy, <strong>and</strong> 33 percent were pursuing their education.In addition, SO percent of the patients who had been in aftercare for 3 monthsor more were completely free of heroin use. A similar statement can be maderegarding the heroin use of patients who were in the community tr(^atnientprograms. As you know, many patients during the <strong>treatment</strong> of their addictionmay abuse drugs other than heroin occasionally, such as cocaine, marihuana,